Tag : humira

Latest News

Biopharma needs a new R&D, innovation model

Newsemia
Strategic partnerships are one way for biopharmaceutical companies to expand capabilities and offerings and proactively define their future versus having it defined for them. Source...
Latest News

Cabaletta raises $38M to develop CAR-T-like cell therapies for autoimmune diseases

Newsemia
The company plans to file an IND in the second half of 2019. The company CEO says the “CAAR-T” therapies may avoid some of the...
Latest News

Cigna boosts its digital platforms for mental health and maternal care

Newsemia
Cigna has been pushing heavily into digital health as evidenced by a venture capital arm it launched earlier this year as well as acquisitions like...
Latest News

McKesson CEO to retire in 2019

Newsemia
John Hammergren, who has served as the company’s CEO for nearly 20 years, will retire next year, and COO Brian Tyler will take his place....
Latest News

Designing a high-value approach to chronic care management

Newsemia
Determining the right approach for member engagement around care management requires deep understanding not only of the factors that put members’ health at risk, but...
Latest News

What CMS’ virtual care moves mean for healthcare at large

Newsemia
In a phone interview, Matt Fisher, a partner with Mirick O’Connell, said CMS’ latest actions regarding virtual care are beneficial but noted doctors shouldn’t forget about...
Latest News

What barriers are preventing patients from getting mental health services?

Newsemia
New research from AbleTo, a provider of tech-enabled behavioral health solutions, found cost and stigma remain two of the primary reasons behind why consumers don’t...
Latest News

How CareMore is tackling loneliness as a clinical issue

Newsemia
At the MedCity ENGAGE conference in San Diego CareMore Health’s Robin Caruso will how the organization has tackled the issue of social isolation head-on, improving...
Latest News

What can healthcare learn from cable? A closer look at the Comcast – Independence joint venture

Newsemia
A fireside chat at MedCity INVEST Twin Cities event between Medical Alley Association CEO and President Shaye Mandle and Gary Zimmer, chief medical advisor for Comcast...
Latest News

How to combat the Bay Area talent crisis in life sciences

Newsemia
Be flexible, creative and aggressive in your search for talent. Consider alternative types of candidates. Recognize what the competition is offering and don’t bury your...
Latest News

What else is needed for price transparency to control costs?

Newsemia
A panel at the MedCity Engage conference in San Diego on Nov. 6 will delve into the methods companies are undertaking to improve price transparency...
Latest News

AdvaMed’s CEO dismissed The Bleeding Edge documentary as “entertainment.” He is wrong.

Newsemia
The CEO of the largest medical device industry association believes The Bleeding Edge documentary to be “entertainment” and not fact-based. What it represents, rather, is...
Latest News

Two months after closing a Series C round, Orchard Therapeutics files for $172.5M IPO

Newsemia
The London-based biotech would trade on the Nasdaq under the ticker symbol ORTX. The move comes two months after it closed a $150 million Series...
Latest News

How are doctors using tech for patient engagement?

Newsemia
In a survey of more than 200 physicians, respondents said they’re currently using various types of technology — including digital waiting room screens, mobile apps...
Latest News

How empowered patients are taking a more active role in their healthcare

Newsemia
At a panel at MedCity’s Engage Conference in San Diego patient advocates will discuss the strategies that can help improve communications, patient experience and engagement....
Latest News

Digital startup focused on women’s and family health secures $27M

Newsemia
The company, Maven, raised funding from investors including Sequoia Capital, Oak HC/FT, 14W, Female Founders Fund and Spring Mountain Capital. Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy